XNAS 05 May, 2026 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Hamid Khoja | Chief Scientific Officer | Purchase of securities on an exchange or from another person at price $ 0.38 per share. | 04 Mar 2026 | 30,000 | 61,250 | - | 0.4 | 11,400 | Common Stock |
| Peter O’Heeron | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 0.38 per share. | 02 Mar 2026 | 15,872 | 5,958,147 | - | 0.4 | 6,006 | Common Stock |
| Peter O’Heeron | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 0.41 per share. | 02 Mar 2026 | 18,200 | 5,942,275 | - | 0.4 | 7,373 | Common Stock |
| Peter O’Heeron | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 0.35 per share. | 02 Mar 2026 | 17,428 | 5,924,075 | - | 0.4 | 6,152 | Common Stock |
| Jason Davis | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.41 per share. | 02 Mar 2026 | 70,000 | 70,000 | - | 0.4 | 28,973 | Common Stock |
| Ruben A. Garcia | General Counsel | Purchase of securities on an exchange or from another person at price $ 0.33 per share. | 27 Feb 2026 | 40,000 | 180,000 | - | 0.3 | 13,056 | Common Stock |
| Ruben A. Garcia | General Counsel | Purchase of securities on an exchange or from another person at price $ 0.34 per share. | 11 Dec 2025 | 140,000 | 140,000 | - | 0.3 | 47,600 | Common Stock |
| Victoria Niklas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Stacy Ann Coen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Matthew Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Robert E. Hoffman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Richard C. Cilento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Jason Davis | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2025 | 450,000 | 450,000 | - | - | Stock Option (Right to Buy) | |
| Hamid Khoja | Chief Scientific Officer | Purchase of securities on an exchange or from another person at price $ 0.84 per share. | 27 May 2025 | 20,000 | 31,250 | - | 0.8 | 16,800 | Common Stock |
| Ruben A. Garcia | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2025 | 189,000 | 189,000 | - | - | Stock Option (Right to Buy) | |
| Hamid Khoja | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2025 | 189,000 | 189,000 | - | - | Stock Option (Right to Buy) | |
| Peter O’Heeron | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2025 | 453,000 | 453,000 | - | - | Stock Option (Right to Buy) | |
| O’Heeron Peter | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Dec 2024 | 406,339 | 406,339 | - | - | Stock Option (Right to Buy) | |
| Khoja Hamid | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Dec 2024 | 176,200 | 176,200 | - | - | Stock Option (Right to Buy) | |
| Garcia Ruben A. | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Dec 2024 | 176,200 | 176,200 | - | - | Stock Option (Right to Buy) | |
| Peter O’Heeron | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Dec 2024 | 100,000 | 5,906,647 | - | 0 | Common Stock | |
| Peter O’Heeron | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Dec 2024 | 50,000 | 6,006,647 | - | 0 | Common Stock | |
| Victoria Niklas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2024 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | |
| Stacy Ann Coen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2024 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | |
| Matthew Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2024 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | |
| Robert E. Hoffman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2024 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | |
| Richard C. Cilento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2024 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | |
| Hamid Khoja | Chief Scientific Officer | Purchase of securities on an exchange or from another person at price $ 1.90 per share. | 12 Aug 2024 | 10,000 | 11,250 | - | 1.9 | 19,000 | Common Stock |
| Peter O’Heeron | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.91 per share. | 12 Aug 2024 | 8,500 | 6,056,647 | - | 1.9 | 16,269 | Common Stock |
| Ruben A. Garcia | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 180,000 | 180,000 | - | - | Stock Option (Right to Buy) |